Investigation of the Occurrence of Serotonin Toxicity in Parkinson's Disease (PD) Patients Treated Concomitantly With Rasagiline and Antidepressants, Using Retrospective Chart Review.

Trial Profile

Investigation of the Occurrence of Serotonin Toxicity in Parkinson's Disease (PD) Patients Treated Concomitantly With Rasagiline and Antidepressants, Using Retrospective Chart Review.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Rasagiline (Primary) ; Antidepressants; Antiparkinsonians
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Acronyms STACCATO
  • Sponsors Teva Pharmaceutical Industries
  • Most Recent Events

    • 08 Jun 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top